Company / Assets per Share
Inhibikase Therapeutics, Inc. Assets per Share History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$15.94
FY2024
5-year range
$0.99 / $15.94
FY2021-FY2024
Trend
+364.1%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Assets per Share changed +364% YoY in FY2024, a notable deviation from the 3-year average annual change of +178%.
Based on SEC 10-K filings.
15.94 in FY2024 with a 3-year CAGR of +55.7%.
Improved from $0.99 to $15.94 over the past 2 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +55.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, assets per share increased 364.1% year-over-year.
Company context
Key Data Points
- Altman Z-Score 0.11 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $15.94 | +364.1% |
| FY2023 | $3.43 | +246.4% |
| FY2022 | $0.99 | -76.5% |
| FY2021 | $4.23 | - |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026